Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229–263
National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology, Version 2. 2023
Salani R, Khanna N, Frimer M et al (2017) An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations. Gynecol Oncol 146:3–10
Oaknin A, Bosse TJ, Creutzberg CL et al (2022) Endometrial cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 33(9):860–877
Yamagami W, Mikami M, Nagase S et al (2020) Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms. J Gynecol Oncol 31(1):e18
Fung-Kee-Fung M, Dodge J, Elit L et al (2006) Follow-up after primary therapy for endometrial cancer: a systematic review. Gynecol Oncol 101(3):520–529
Siegenthaler F, Lindemann K, Epstein E et al (2022) Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification. Gynecol Oncol 165(2):230–238
Odagiri T, Watari H, Hosaka M et al (2011) Multivariate survival analysis of the patients with recurrent endometrial cancer. J Gynecol Oncol 22(1):3–89
Kurra V, Krajewski K, Jagannathan J et al (2013) Typical and atypical metastatic sites of recurrent endometrial carcinoma. Cancer Imaging 13(1):113–122
Lin LL, Grigsby PW, Powell MA et al (2005) Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer. Int J Radiat Oncol Biol Phys 63:500–504
Sears JD, Greven KM, Hoen HM et al (1994) Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer. Cancer 74:1303–1308
Huh WK, Straughn JM Jr, Mariani A et al (2007) Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience. Int J Gynecol Cancer 17:886–889
Jhingran A, Burke TW, Eifel PJ (2003) Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. Int J Radiat Oncol 56:1366–1372
Jeppesen MM, Jensen PT, Gilså Hansen D et al (2016) The nature of early-stage endometrial cancer recurrence—a national cohort study. Eur J Cancer 69:51–60
Curran WJ Jr, Whittington R, Peters AJ et al (1988) Vaginal recurrences of endometrial carcinoma: the prognostic value of staging by a primary vaginal carcinoma system. Int J Radiat Oncol Biol Phys 15(4):803–808
de Boer SM, Powell ME, Mileshkin L et al (2018) Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial. Lancet Oncol 19:295–309
Matei D, Filiaci V, Randall ME et al (2019) Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer. N Engl J Med 380:2317–2326
Nomura H, Aoki D, Susumu N et al (2019) Analysis of the relapse patterns and risk factors of endometrial cancer following postoperative adjuvant chemotherapy in a phase III randomized clinical trial. Gynecol Oncol 155:413–419
Lee JY, Kim JH, Seo JW et al (2016) Detecting asymptomatic recurrence in early-stage endometrial cancer: the value of vaginal cytology, imaging studies, and CA-125. Int J Gynecol Cancer 26(8):1434–1439
Podczaski E, Kaminski P, Gurski K et al (1992) Detection and patterns of treatment failure in 300 consecutive cases of early endometrial cancer after primary. Gynecol Oncol 47:323–327
Shumsky AG, Stuart GCE, Brasher PM et al (1994) An evaluation of routine follow-up of patients treated for endometrial carcinoma. Gynecol Oncol 55:229–233
Berchuck A, Anspach C, Evans AC et al (1995) Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma. Gynecol Oncol 59:20–24
Reddoch J, Burke T, Morris M et al (1995) Surveillance for recurrent endometrial carcinoma: development of a follow-up. Gynecol Oncol 59:221–225
Owen P, Duncan I (1996) Is there any value in the long term follow up of women treated for endometrial cancer? BJOG 103:710–713
Agboola OO, Grunfeld E, Coyle D et al (1997) Costs and benefits of routine follow-up after curative treatment for endometrial cancer. CMAJ 157(7):879–886
Ng TY, Ngan HY, Cheng DK et al (1997) Vaginal vault cytology in the routine follow-up of patients treated for endometrial carcinoma: is it useful? Aust N Z J Obstet Gynaecol 37(1):104–106
Salvesen T, Fellow R, Akslen T et al (1997) Recurrence of endometrial carcinoma and the value of routine follow up. BJOG 104:1302–1307
Morice P, Levy-Piedbois C, Ajaj S et al (2001) Value and cost evaluation of routine follow-up for patients with clinical stage I/II endometrial cancer. Eur J Cancer 37(8):985–990
Carrara L, Gadducci A, Landoni F et al (2012) Could different follow-up modalities play a role in the diagnosis of asymptomatic endometrial cancer relapses? An Italian multicentric retrospective analysis. Int J Gynecol Cancer 22(6):1013–1019
Mandato VD, Mastrofilippo V, Palicelli A et al (2021) Solitary vulvar metastasis from early-stage endometrial cancer: case report and literature review. Medicine (Baltimore) 100(22):e25863
Steiner A, Alban G, Cheng T et al (2020) Vaginal recurrence of endometrial cancer: MRI characteristics and correlation with patient outcome after salvage radiation therapy. Abdom Radiol 45(4):1122–1131
Aalders J, Abeler V, Kolstad P et al (1984) Recurrent adenocarcinoma od the endometrium: a clinical and histopathological study of 379 patients. Gynecol Oncol 17:85–103
Zola P, Ciccone G, Piovano E et al (2022) Effectiveness of intensive versus minimalist follow-up regimen on survival in patients with endometrial cancer (TOTEM Study): a randomized, pragmatic, parallel group, multicenter trial. J Clin Oncol 20(40):3817–3827
Comments (0)